MedTrace Logo

The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension

NCT00471003 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5448

Last updated 2010-01-20

No results posted yet for this study

Summary

The main purpose of this study is to asses the efficacy and safety of telmisartan, with the special attention on the influence of telmisartan on selected metabolic parameters of patients.

Conditions

Interventions

DRUG

Pritor (Telmisartan , BAY68-9291)

Primary care hypertensive patients starting the therapy with Telmisartan

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • Croatia
  • Poland
  • Slovakia
  • Slovenia

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00471003 on ClinicalTrials.gov